Phase 1 Haematologic Disease Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Phase I Study of CTL Anti-DP Infusion Post-hematopoietic Stem Cell Transplantation

Haematologic Disease

Nantes University Hospital6 enrolled1 locationNCT04180059

Recruiting

Phase 1Phase 2

A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma

NeoplasmsMultiple MyelomaParaproteinemias+5 more

Hellenic Society of Hematology36 enrolled2 locationsNCT05573802